Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05971381 · ClinicalTrials.gov registry record · NA
Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells
A NA study of Vitiligo, sponsored by Avita Medical.
- Completed
- Registry status
- NA
- Development phase
- 109
- Enrollment target
- 17
- Study locations
NCT05971381 is a NA study of Vitiligo that has completed, run by Avita Medical. The registered enrollment target is 109 participants, below the 1,117-participant average among 15 other Vitiligo trials with a reported enrollment target (90% lower). The trial reports 17 study locations across 9 states.
The verdict
NCT05971381, a NA study of Vitiligo, has completed, sponsored by Avita Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 109 participants
- Enrollment target
- 17
- Study locations
Study Summary
To evaluate repigmentation and quality of life after treatment of stable vitiligo lesions using the RECELL Device.
Conditions Studied
Interventions
- DEVICE RECELL® Autologous Cell Harvesting Device
Study Locations (17)
California
- University of California, Irvine - Irvine
- West Dermatology Research Center - San Diego
- Sutter Health - Sunnyvale
- California Dermatology Institute - Thousand Oaks
Michigan
- Hamzavi Dermatology - Canton
- Henry Ford Health - Detroit
- Grekin Skin Institute - Warren
Florida
- Siperstein Dermatology Group - Boynton Beach
- Skin Care Research, LLC - Hollywood
Maryland
- Dermatologic Surgery Center of Washington - Chevy Chase
- Maryland Laser, Skin & Vein Institute - Hunt Valley
New York
- The Dermatology Specialist - New York
- Mount Sinai - New York
Arizona
- Affiliated Dermatology - Scottsdale
Colorado
- Clarity Dermatology - Castle Rock
Massachusetts
- University Of Massachusetts - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2023-08-14 |
| Est. Completion | 2025-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05971381
The ClinicalTrials.gov registry entry for NCT05971381 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,117-participant average among 15 other Vitiligo trials with a reported enrollment target (90% lower). The listed sponsor is Avita Medical, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vitiligo appearing as the primary indexed condition, and to 1 intervention - of which RECELL® Autologous Cell Harvesting Device is the first listed.
NCT05971381 reports 17 study locations spanning 9 distinct geographic areas - top geographies include California, Michigan, Florida.
Frequently Asked Questions
What is clinical trial NCT05971381 about?
NCT05971381 is a clinical study titled "Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells". To evaluate repigmentation and quality of life after treatment of stable vitiligo lesions using the RECELL Device.
What is the current status of trial NCT05971381?
This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2023-08-14. Estimated completion is 2025-01-31.
What conditions does trial NCT05971381 study?
This clinical trial studies the following conditions: Vitiligo.
What interventions are being tested in trial NCT05971381?
The interventions under investigation include: RECELL® Autologous Cell Harvesting Device (DEVICE).
Who is sponsoring clinical trial NCT05971381?
This trial is sponsored by Avita Medical, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05971381 being conducted?
This trial has 17 study locations across Arizona, California, Colorado, Florida, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vitiligo
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Photocil (Topical) for the Treatment of Vitiligo
COMPLETED · NA
-
Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy
COMPLETED · NA
-
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
RECRUITING · Phase 1
-
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
RECRUITING · Phase 3
-
The Gut and Skin Microbiome in Vitiligo Disease Progression
RECRUITING
-
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.